Pharmidex are taking all the necessary steps to ensure the progression of client studies during these difficult time.
COVID-19: Pharmidex Contingency Plan
We are taking all necessary steps to ensure that studies proceed, while preserving the health and safety of staff. Summary of key steps taken at Pharmidex:
- Following the relevant guidelines issued by Public Health England.
- Limiting access to only essential people in our laboratories and cancelling/rescheduling all non-critical visitors. All visitors must confirm COVID-19 status prior to arrival.
- Cancelled all non-essential business travel.
- Closely communicating with suppliers regarding the status of their inventories and their business continuity plans and identifying alternate sources for supplies.
- Implemented strict sanitization practices to prevent cross contamination between staff, including providing our staff with resources and up-to-date information and guidance.
- To prevent the potential spread of the infection amongst employees, staff will declare any potential close contact with infected individuals and follow the relevant health guidelines.
- Our operations team will ensure adequate staffing cover so as not to compromise client studies.
We will keep you updated if the situation changes resulting in any impact on progression of your projects.
Best wishes to everyone during these tough times.
Pharmidex is proud to sponsor the SMR meeting Target Identification and Validation in Drug Discovery
